 NEW YORK, March 07, 2021 GLOBE NEWSWIRE -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of Immunovant, Inc. Immunovant or the Company NASDAQ: IMVT from October 2, 2019 through February 1, 2021 the Class Period. The lawsuit filed in the United States District Court for the Eastern District of New York alleges violations of the Securities Exchange Act of 1934. 